MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

28 Oct 2021 Evaluate
The Turnover for the quarter ended September 2021 of Rs. 335.12 millions increase by 50.89% from Rs. 222.09 millions.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 40.36  millions as against Rs. 42.63 millions reported during the corresponding quarter ended.Operating profit for the quarter ended September 2021 decreased to 54.94 millions as compared to 57.20 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 335.12 222.09 50.89 626.92 433.62 44.58 868.71 456.33 90.37
Other Income 2.32 5.19 -55.30 12.24 19.87 -38.40 18.10 5.95 204.20
PBIDT 54.94 57.20 -3.95 114.57 120.17 -4.66 206.98 92.73 123.21
Interest 0.14 0.00 0.00 0.17 0.00 0.00 0.13 0.00 0.00
PBDT 54.80 57.20 -4.20 114.40 120.17 -4.80 206.85 92.73 123.07
Depreciation 0.67 0.30 123.33 0.93 0.37 151.35 0.88 0.08 1000.00
PBT 54.13 56.90 -4.87 113.47 119.80 -5.28 205.97 92.65 122.31
TAX 13.77 14.27 -3.50 28.78 30.10 -4.39 54.64 27.70 97.26
Deferred Tax 0.22 -0.01 -2300.00 0.21 0.04 425.00 0.04 0.04 0.00
PAT 40.36 42.63 -5.32 84.69 89.70 -5.59 151.33 64.95 132.99
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 16.39 25.76 -36.35 18.28 27.71 -34.06 23.83 20.32 17.25
Peers